RVMD - Revolution Medicines stock rallies 21% amid data presentations
2023-10-13 14:01:47 ET
More on Revolution Medicines
- Revolution Medicines: A Big Pipeline In Need Of Big Data
- Revolution Medicines' Strategic Edge In RAS-Driven Oncology
- Revolution Medicines, Inc. (RVMD) Q2 2023 Earnings Call Transcript
- Revolution Medicines will buy EQRx in an all-stock transaction
- Seeking Alpha’s Quant Rating on Revolution Medicines
For further details see:
Revolution Medicines stock rallies 21% amid data presentations